SCHEMBL5509718

SCHEMBL5509718

COCCCC[C@@](O)(c1cccc(F)c1OCC1CC1)C1CCCN(C(=O)O)C1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.56
CYP3A4 P08684 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1863306 0.90 REN (0.55) RENCYP3A4
SCHEMBL1863304 0.90 REN (0.55) RENCYP3A4
SCHEMBL5593562 0.86 REN (0.48) RENCYP3A4
SCHEMBL8269143 0.86 REN (0.54) RENCYP3A4
SCHEMBL4754618 0.84 REN (0.69) RENCYP3A4
SCHEMBL1865140 0.84 REN (0.69) REN
SCHEMBL1862835 0.84 REN (0.69) REN
SCHEMBL1861751 0.84 REN (0.69) REN
SCHEMBL1865775 0.84 REN (0.69) REN
SCHEMBL1865778 0.84 REN (0.69) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007117560-A2 PIPERIDINE AND MORPHOLINE RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-10-18 WO disclosed
EP-1807078-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2007-07-18 EP disclosed
WO-2006042150-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-04-20 WO disclosed